Fundraising Fox

Arbor Biotechnologies

Cambridge, US · Founded 2016 · Delaware corporation · 5 known investors

arbor.bio

Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches. The company is developing a portfolio of DNA editing technologies capable of targeting over 90% of the human genome for therapeutic applications.

BiotechDigital HealthMedical Devicesin /arborbio@arbortx

Founders & leadership

KC
KEITH CRANDELLDirector
DA
DAVID ARTHUR SCOTTExecutive Officer
WX
WINSTON XIA YANExecutive Officer
AH
ANNIE HAZLEHURSTDirector
FZ
FENG ZHANGDirector
DR
DAVID R. WALTDirector

Investors · 5

Reported raises · per SEC filings

Form D private placements
$215MraisedNov 2021 · 37 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • DAVID CHENGExecutive Officer
  • PAUL MEISTERDirector
  • RAMI HARAWIDirector
  • KEITH CRANDELLDirector
  • KELLY MORGANExecutive Officer
  • JOHN MURPHYExecutive Officer
  • MARK ANGELINODirector
  • PAM STETKIEWICZExecutive Officer
  • DEVYN SMITHExecutive Officer, Director
  • CHEN YUDirector
  • DAVID WALTDirector
Offering amount
$215M
Amount sold
$215M
First sale
Oct 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$15.6MraisedAug 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • KEITH CRANDELLDirector
  • DAVID R. WALTDirector
  • DAVID ARTHUR SCOTTExecutive Officer
  • WINSTON XIA YANExecutive Officer
  • ANNIE HAZLEHURSTDirector
  • FENG ZHANGDirector
Offering amount
$15.6M
Amount sold
$15.6M
First sale
May 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.